BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18470430)

  • 1. [Expression of bcl-2 and survivin gene products in different stages of vessel differentiation in hemangiomas].
    Tan HS; Qin XJ; Wang XK
    Shanghai Kou Qiang Yi Xue; 2008 Apr; 17(2):204-7. PubMed ID: 18470430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of cellular adhesion molecules and HLA-DR antigen on vascular endothelial cells in hemangiomas.].
    Qin XJ; Qiu P; Wang XK; Sun CF; Li QC; Han YC; Guan XF
    Shanghai Kou Qiang Yi Xue; 2004 Oct; 13(5):421-5. PubMed ID: 15514871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hydrogel-endothelial cell implant mimics infantile hemangioma: modulation by survivin and the Hippo pathway.
    Tsuneki M; Hardee S; Michaud M; Morotti R; Lavik E; Madri JA
    Lab Invest; 2015 Jul; 95(7):765-80. PubMed ID: 25961170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-143 acts as a suppressor of hemangioma growth by targeting Bcl-2.
    Huang C; Huang J; Ma P; Yu G
    Gene; 2017 Sep; 628():211-217. PubMed ID: 28716710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomolecular markers and involution of hemangiomas.
    Frischer JS; Huang J; Serur A; Kadenhe A; Yamashiro DJ; Kandel JJ
    J Pediatr Surg; 2004 Mar; 39(3):400-4. PubMed ID: 15017560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local serum levels of vascular endothelial growth factor in infantile hemangioma: intriguing mechanism of endothelial growth.
    Przewratil P; Sitkiewicz A; Andrzejewska E
    Cytokine; 2010 Feb; 49(2):141-7. PubMed ID: 20015661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of apoptosis and Bcl-2, Bax in hemangioma and vascular malformations].
    Wang B; Zhuang FL; Zhang PF; Zhang S; Lin H
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2003 Sep; 19(5):347-9. PubMed ID: 15179873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular markers that distinguish the phases of hemangioma during infancy and childhood.
    Takahashi K; Mulliken JB; Kozakewich HP; Rogers RA; Folkman J; Ezekowitz RA
    J Clin Invest; 1994 Jun; 93(6):2357-64. PubMed ID: 7911127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and significance of TRAIL protein and mRNA in hemangioma].
    Lin H; Chen SH; Yin GQ; Li D; Liu QF
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 Mar; 23(2):93-6. PubMed ID: 17554866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infantile hemangioma is a proliferation of LYVE-1-negative blood endothelial cells without lymphatic competence.
    Nguyen VA; Kutzner H; Fürhapter C; Tzankov A; Sepp N
    Mod Pathol; 2006 Feb; 19(2):291-8. PubMed ID: 16424896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression of CEACAM-1 and CXCL-14 in infantile hemangioma].
    Xu GQ; Lü RR; Huo R; Guo X
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 May; 26(3):195-8. PubMed ID: 20737948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of glucocorticoid receptor isoforms in cutaneous hemangiomas and vascular malformations.
    Jiang XW; Wang GH; Li JH; Chen ZX; He F
    Chin Med J (Engl); 2005 Jun; 118(12):977-81. PubMed ID: 15978204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation patients.
    Zhang L; Lin X; Wang W; Zhuang X; Dong J; Qi Z; Hu Q
    Plast Reconstr Surg; 2005 Jul; 116(1):200-4. PubMed ID: 15988268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indentification of differentially expressed genes in proliferating and involuting hemangiomas by cDAN microarray analysis of gene-expression profiles].
    Zhang L; Wang W; Qi ZL; Dong JS; Song HD; Yang JS; Lin XX
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2003 Nov; 19(6):452-5. PubMed ID: 15004904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The expression and significance of beta2-AR and VEGFR-2 in infantile hemangioma].
    Xu G; Niu J; Lyu R; Zhou S; Huo R
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2014 Jul; 30(4):274-8. PubMed ID: 25322575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the role of serum vascular endothelial growth factor and urinary basic fibroblast growth factor in differential diagnosis of vascular anomalies].
    Zhang L; Chen Q; Li D; Li XW; Wang HG; Li GZ
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1092-5. PubMed ID: 21609589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in children with hemangiomas and vascular malformations--preliminary report.
    Przewratil P; Sitkiewicz A; Wyka K; Andrzejewska E
    Pediatr Dermatol; 2009; 26(4):399-404. PubMed ID: 19689513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIAA1429 promotes infantile hemangioma regression by facilitating the stemness of hemangioma endothelial cells.
    Wang L; Zou Y; Huang Z; Wang W; Li J; Bi J; Huo R
    Cancer Sci; 2023 Apr; 114(4):1569-1581. PubMed ID: 36572002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling.
    Calicchio ML; Collins T; Kozakewich HP
    Am J Pathol; 2009 May; 174(5):1638-49. PubMed ID: 19349369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF Pathway Gene Expression Profile of Proliferating versus Involuting Infantile Hemangiomas: Preliminary Evidence and Review of the Literature.
    Heredea RE; Melnic E; Cirligeriu LE; Berzava PL; Stănciulescu MC; Popoiu CM; Cimpean AM
    Children (Basel); 2022 Jun; 9(6):. PubMed ID: 35740845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.